Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvista in Split Skin Graft Donor Sites
NCT00984503Phase 2Completed
- Sponsor
- Renovo
- Start
- Oct 2003
- Primary completion
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of avotermin in cicatrix and wound healing (4 arms), sponsored by Renovo. Primary endpoint: Accelerated healing potential at 12 months. Started Oct 2003; status: completed.
02
Drugs
avotermin
03
Conditions
cicatrixwound healing
Beyond the preview
Go deeper on NCT00984503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984503.